Stock Updates

Eli Lilly and Company (NYSE: LLY) – Is this large market cap stock undervalued?

Eli Lilly and Company (NYSE: LLY), is firmly in the large market cap category with market cap of 88199.51. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Eli Lilly and Company is 80.14 (with a change from open of 0.27%), this in conjunction with a target price of 97.6. Volume today has so far reached 1209537, with an average volume of about 3461.58. The GAP for this stock, is -0.72%.

The P/E ratio is 34.7, bringing the forward P/E to a value of 19.7. The current EPS for Eli Lilly and Company, is 2.32, with a EPS growth for this year coming to a value of 1.60%. Performance has been interesting with performance year to date coming to -2.53%.

Looking further into the growth statistics for Eli Lilly and Company, EPS is looking like it will grow 13.91% in the next year. Looking even further it is projected to be 13.17%. Quarter over quarter is 25.10% for EPS growth and for sales growth quarter over quarter it is 8.60%. Looking at past EPS growth statistics we see that for the past five years it has been -13.20%. Sales growth for the past five years has in fact been -2.90%.

Looking at the ownership, we see that the insider ownership is at 11.40% and institutional ownership is 77.00%. Shares outstanding is 1095.51, while shares float is at a value of 1095.51. Float short for Eli Lilly and Company is 0.59% and the short ratio is 1.88.

In terms of debt, long term debt/equity is 0.59, while the total debt/equity comes to 0.64. The ability to meet these debts, means that the current ratio is 1.5, and the quick ratio is 1.1. The most recent gross margin is 73.70% and their operating margin is 14.60%. The profit margin is 12.00%.

Eli Lilly and Company has seen returns on assets of 6.90%, and on investment, 9.50%. Return on equity is 16.60%. Price/Earnings to growth ratio is 2.63. Price/Sales ratio is at a value of 4.28, with Price/book ratio coming to 5.82 and Price/cash is 22.42, and finally Price/Free cash Flow is *TBA.

The simple moving averages are 0.34% and 4.57% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -7.26% and the 52 week low is 19.61%.

Eli Lilly and Company has a dividend yield of 2.53%, with a current price of 80.14. The ability to pay this means the payout ratio is 91.20%. This is in an industry, Drug Manufacturers – Major, with equally high dividends from other companies in this sector, which it is Healthcare. Eli Lilly and Company is based in USA.

Performance in the Drug Manufacturers – Major industry means that Eli Lilly and Company has seen performance for the past week of -1.52%, with performance for the month coming to 2.59%. Looking at the data for the quarter it is at a value of 0.54%, and for the half year the performance is 3.81%. Volatility for this week is 1.62% and for the month this is 1.40%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment